Express Pharma

Stability test: A step towards progress?

11

DCG(I) has come up with mandatory provisions for pharma companies to undergo stability tests for approval of drugs in India. Though it will raise the standard for quality of drugs in the global market, it will also have considerable impact on pharma company’s bottom line. Industry experts have a mixed bag of opinions

[email protected]

Bhavin Mehta, Director, Kilitch Drugs

SV Veeramani, CMD, Fourrts Laboratories

Dr Dinesh Dua, Chairman, Pharmexcil; Chairman, Entrepreneurship & Start Ups, CII North India; CEO & Director, Nectar Lifesciences

BR Sikri, President, FOPE

Nipun Jain, CEO, Pharmchem

Vishnukant Bhutada, MD, Shilpa Medicare

Comments are closed.